Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verrica Pharmaceuticals (VRCA) Amortization of Deferred Charges (2021)

Historic Amortization of Deferred Charges for Verrica Pharmaceuticals (VRCA) over the last 1 years, with Q4 2021 value amounting to $58000.0.

  • Verrica Pharmaceuticals' Amortization of Deferred Charges changed N/A to $58000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $228000.0, marking a year-over-year change of. This contributed to the annual value of $228000.0 for FY2021, which is 2258.06% up from last year.
  • Per Verrica Pharmaceuticals' latest filing, its Amortization of Deferred Charges stood at $58000.0 for Q4 2021.
  • Verrica Pharmaceuticals' 5-year Amortization of Deferred Charges high stood at $58000.0 for Q4 2021, and its period low was $56000.0 during Q1 2021.